Akums Drugs & Pharmaceuticals has introduced Paracetamol Oral Suspension 500mg/5ml to the Indian market, offering a high-strength liquid formulation aimed at enhancing pain and fever management in adult and elderly patients.
This new launch represents a significant advancement in the analgesic and antipyretic segment by delivering a therapeutic adult dose in just 5ml, making it easier to administer and more convenient for patients who struggle with swallowing tablets. The formulation addresses a critical need for liquid alternatives in adult care—particularly for geriatric patients, those recovering from surgery, and individuals with dysphagia.
By offering one of the most concentrated paracetamol suspensions currently available in India, Akums fills a long-standing gap between paediatric syrups and adult tablets. The simplified dosing—500mg in a single 5ml spoonful—reduces both dose volume and frequency, making it particularly suitable for use in outpatient care, hospital wards, and home health settings.
This ready-to-use format enhances treatment adherence, especially in real-world situations where IV access is limited, tablets are not well tolerated, or there is a need for quick symptom relief. Compared to conventional 250mg/5ml suspensions, which require double the volume for the same dose, the 500mg/5ml formulation minimizes confusion and streamlines administration, offering a practical solution for caregivers and healthcare providers.
With this launch, Akums strengthens its commitment to patient-centric innovation, delivering a formulation tailored to India’s growing need for accessible, effective, and user-friendly therapies.